Copyright
©The Author(s) 2019.
World J Gastroenterol. Jun 7, 2019; 25(21): 2603-2622
Published online Jun 7, 2019. doi: 10.3748/wjg.v25.i21.2603
Published online Jun 7, 2019. doi: 10.3748/wjg.v25.i21.2603
Figure 1 Candidate compound screening and corresponding target matching for Jian-Pi Qing-Chang.
A: Compound-targets networks were constructed for the candidate compounds of each Chinese herb of Jian-Pi Qing-Chang (JPQC) and their corresponding targets; B: An integrated compound-targets network was constructed for all the putative compounds of JPQC and their corresponding targets. JPQC: Jian-Pi Qing-Chang; AM: Astragali mongholicus; CP: Codonopsis pilosula; POL: Portulaca oleracea L; RS: Radix sanguisorbae; PN: Panax notoginseng; BR: Bletillae rhizoma; RA: Radix aucklandiae; CC: Coptis chinensis; RG: Radix glycyrrhizae.
- Citation: Chen YL, Zheng YY, Dai YC, Zhang YL, Tang ZP. Systems pharmacology approach reveals protective mechanisms of Jian-Pi Qing-Chang decoction on ulcerative colitis. World J Gastroenterol 2019; 25(21): 2603-2622
- URL: https://www.wjgnet.com/1007-9327/full/v25/i21/2603.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i21.2603